Benzinga
Benzinga
Notizie dall’Italia
Azioni
Indici
Obbligazioni
ETF
Economia
Generale
Notizie USA
Azioni
Indici
Utili
Notizie Economiche
Mercati di previsione
Mercati privati
Altri Mercati
Dicono gli Analisti
Trading
Comunicati stampa
Notizie internazionali
Europa
Asia
Criptovalute
Notizie
Altcoin
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Finanza personale
Investire in criptovalute
Investire in azioni
Forex
Benzinga
mercoledì, novembre 18
Notizie dall’Italia
Azioni
Indici
Obbligazioni
ETF
Economia
Generale
Notizie USA
Azioni
Indici
Utili
Notizie Economiche
Mercati di previsione
Mercati privati
Altri Mercati
Dicono gli Analisti
Trading
Comunicati stampa
Notizie internazionali
Europa
Asia
Criptovalute
Notizie
Altcoin
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Finanza personale
Investire in criptovalute
Investire in azioni
Forex
OS Therapies Inc
OSTX
AMEX
Watchlist
Get Report
Trade with Public
Get Report
Trade with Public
$0.8740
0.13
17.35%
Ult. Agg.: Nov 18, 10:04 AM
Get Report
Panoramica
Notizie
Grafici
Previsioni utili
Eventi
Obiettivi di prezzo
Dati finanziari
Sentiment
Azionariato
Confronta
Rapporto azionario
OS Therapies Financials
OS Therapies (OSTX) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
Earnings Scheduled For May 18, 2026
Benzinga Insights
PRO
OS Therapies Q1 EPS $(0.27) Misses $(0.18) Estimate
OS Therapies (AMEX:OSTX) reported quarterly losses of $(0.27) per share which missed the analyst consensus estimate of $(0.18) by 50 percent. This is a 50 percent decrease over losses of $(0.18) per share from the same
Benzinga Newsdesk
PRO
OS Therapies Q4 EPS $(0.41) Misses $(0.13) Estimate
OS Therapies (AMEX:OSTX) reported quarterly losses of $(0.41) per share which missed the analyst consensus estimate of $(0.13) by 228 percent. This is a 70.83 percent decrease over losses of $(0.24) per share from the
Benzinga Newsdesk
PRO
OS Therapies Q3 EPS $(0.21) Misses $(0.13) Estimate
Benzinga Newsdesk
PRO
OS Therapies Q2 EPS $(0.19) Misses $(0.12) Estimate
OS Therapies (AMEX:OSTX) reported quarterly losses of $(0.19) per share which missed the analyst consensus estimate of $(0.12) by 65.22 percent. This is a 26.92 percent increase over losses of $(0.26) per share from the
Benzinga Newsdesk
Earnings Outlook For OS Therapies
Benzinga Insights